VEGF plasma level variations in duloxetine-treated patients with major depression

Journal of Affective Disorders

Volumn 151, Issue 2, 2013, Pages 590-595

  Fornaro, Michele ^a,b   Rocchi, Giulio ^a   Escelsior, Andrea ^a   Contini, Paola ^a   Ghio, Massimo ^a   Colicchio, Salvatore ^c   De Berardis, Domenico ^d   Amore, Mario ^a   Fornaro, Pantaleo ^a   Martino, Matteo ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Depression; Duloxetine; Neurovascular unit; VEGF

Indexed keywords

DULOXETINE; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HAMILTON SCALE; HUMAN; HUMAN TISSUE; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOPHARMACOTHERAPY; STRESS; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TREATMENT DURATION; YOUNG MANIA RATING SCALE;

DEPRESSION; DULOXETINE; NEUROVASCULAR UNIT; VEGF;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; THIOPHENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885471898     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2013.06.055     Document Type: Article

References (65)

1. A.P.A Diagnostic and Statistical Manual for Mental Disorders fourth ed. 1994 American Psychiatrich Association Washington
2. I. Allaman, H. Fiumelli, P.J. Magistretti, and J.L. Martin Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes Psychopharmacology (Berlin) 216 2011 75 84
3. M. Asberg, A. Nygren, R. Leopardi, G. Rylander, U. Peterson, L. Wilczek, H. Kallmen, M. Ekstedt, T. Akerstedt, M. Lekander, and R. Ekman Novel biochemical markers of psychosocial stress in women PLoS One 4 2009 e3590
4. C.M. Bloor Angiogenesis during exercise and training Angiogenesis 8 2005 263 271
5. H.P. Blumberg, F. Wang, L.G. Chepenik, J.H. Kalmar, E. Edmiston, R.S. Duman, and J. Gelernter Influence of vascular endothelial growth factor variation on human hippocampus morphology Biological Psychiatry 64 2008 901 903
6. F. Cirulli, and E. Alleva The NGF saga: from animal models of psychosocial stress to stress-related psychopathology Frontiers in Neuroendocrinology 30 2009 379 395
7. P. Dome, Z. Halmai, J. Dobos, J. Lazary, X. Gonda, I. Kenessey, T. Sallai, Z. Makkos, and G. Faludi Investigation of circulating endothelial progenitor cells and angiogenic and inflammatory cytokines during recovery from an episode of major depression Journal of Affective Disorders 136 2012 1159 1163
8. B. Elfving, P.H. Plougmann, and G. Wegener Differential brain, but not serum VEGF levels in a genetic rat model of depression Neuroscience Letters 474 2010 13 16
9. B. Elfving, and G. Wegener Electroconvulsive seizures stimulate the vegf pathway via mTORC1 Synapse 66 2012 340 345
10. E. Emanuele, P. Orsi, F. Barale, S.U. di Nemi, M. Bertona, and P. Politi Serum levels of vascular endothelial growth factor and its receptors in patients with severe autism Clinical Biochemistry 43 2010 317 319
11. D.S. Faffe, L. Flynt, K. Bourgeois, R.A. Panettieri Jr.; and S.A. Shore Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype American Journal of Respiratory Cell and Molecular Biology 34 2006 213 218
12. L.W. Feurino, Y. Zhang, U. Bharadwaj, R. Zhang, F. Li, W.E. Fisher, F.C. Brunicardi, C. Chen, Q. Yao, and L. Min IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells Cancer Biology & Therapy 6 2007 1096 1100
13. L. Fioravanzo, M. Venturini, R.D. Liddo, F. Marchi, C. Grandi, P.P. Parnigotto, and M. Folin Involvement of rat hippocampal astrocytes in beta-amyloid-induced angiogenesis and neuroinflammation Current Alzheimer Research 7 2010 591 601
14. M. Fornaro, F. Bandini, C. Ogliastro, C. Cordano, M. Martino, L. Cestari, A. Escelsior, G. Rocchi, S. Colicchio, and G. Perugi Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background? Journal of Affective Disorders 135 2011 154 159
15. M. Fornaro, M. Martino, F. Battaglia, S. Colicchio, and G. Perugi Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation Journal of Neuropsychiatric Disease and Treatment 7 2011 51 56
16. M. Fornaro, G. Rocchi, A. Escelsior, P. Contini, and M. Martino Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds Journal of Affective Disorders 2012
17. N.M. Fournier, and R.S. Duman Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression Behavioural Brain Research 227 2012 440 449
18. J.M. Fredriksson, J.M. Lindquist, G.E. Bronnikov, and J. Nedergaard Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta -adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2 The Journal of Biological Chemistry 275 2000 13802 13811
19. S. Fulzele, and A. Pillai Decreased VEGF mRNA expression in the dorsolateral prefrontal cortex of schizophrenia subjects Schizophrenia Research 115 2009 372 373
20. R. Gomez, H. Ferrero, F. Delgado-Rosas, M. Gaytan, C. Morales, R.C. Zimmermann, C. Simon, F. Gaytan, and A. Pellicer Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment Journal of Clinical Endocrinology and Metabolism 96 2011 2484 2492
21. J. Greene, M. Banasr, B. Lee, J. Warner-Schmidt, and R.S. Duman Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization Neuropsychopharmacology 34 2009 2459 2468
22. M. Hamilton A rating scale for depression Journal of Neurology, Neurosurgery & Psychiatry 23 1960 56 62
23. D.D. Han, Y. Wang, X.H. Zhang, J.R. Liu, and H.L. Wang Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1alpha and vascular endothelial growth factor Canadian Journal of Physiology and Pharmacology 2012
24. K.R. Howell, A. Kutiyanawalla, and A. Pillai Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex PLoS One 6 2011 e20198
25. L. Ibrahim, W. Duncan, D.A. Luckenbaugh, P. Yuan, R. Machado-Vieira, and C.A. Zarate Jr. Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot study Brain Research Bulletin 86 2011 129 133
26. J. Iga, S. Ueno, K. Yamauchi, S. Numata, S. Tayoshi-Shibuya, S. Kinouchi, M. Nakataki, H. Song, K. Hokoishi, H. Tanabe, A. Sano, and T. Ohmori Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 2007 658 663
27. R.W. Invernizzi, and S. Garattini Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies Progress in Neuro-Psychopharmacology & Biological Psychiatry 28 2004 819 827
28. J. Isung, F. Mobarrez, P. Nordstrom, M. Asberg, and J. Jokinen Low plasma vascular endothelial growth factor (VEGF) associated with completed suicide The World Journal of Biological Psychiatry 2011
29. K.G. Kahl, S. Bens, K. Ziegler, S. Rudolf, A. Kordon, L. Dibbelt, and U. Schweiger Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder Psychoneuroendocrinology 34 2009 353 357
30. V. Kannen, T. Marini, A. Turatti, M.C. Carvalho, M.L. Brandao, V.A. Jabor, P.S. Bonato, F.R. Ferreira, D.L. Zanette, W.A. Silva Jr.; and S.B. Garcia Fluoxetine induces preventive and complex effects against colon cancer development in epithelial and stromal areas in rats Toxicology Letters 204 2011 134 140
31. S. Katsuura, Y. Kamezaki, N. Yamagishi, Y. Kuwano, K. Nishida, K. Masuda, T. Tanahashi, T. Kawai, K. Arisawa, and K. Rokutan Circulating vascular endothelial growth factor is independently and negatively associated with trait anxiety and depressive mood in healthy Japanese university students International Journal of Psychophysiology 81 2011 38 43
32. K. Kikuchi, J.I. Iga, S. Tayoshi, M. Nakataki, S. Watanabe, S. Numata, and T. Ohmori Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder Human Psychopharmacology 2011
33. T. Kiuchi, H. Lee, and T. Mikami Regular exercise cures depression-like behavior via VEGF-Flk-1 signaling in chronically stressed mice Neuroscience 207 2012 208 217
34. S.K. Kwon, E. Kovesdi, A.B. Gyorgy, D. Wingo, A. Kamnaksh, J. Walker, J.B. Long, and D.V. Agoston Stress and traumatic brain injury: a behavioral, proteomics, and histological study Frontiers in Neurology 2 2011 12
35. K.B. Lai, J.E. Sanderson, and C.M. Yu The regulatory effect of norepinephrine on connective tissue growth factor (CTGF) and vascular endothelial growth factor (VEGF) expression in cultured cardiac fibroblasts International Journal of Cardiology 2011
36. B.H. Lee, and Y.K. Kim Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders Journal of Affective Disorders 136 2012 181 184
37. T. Licht, I. Goshen, A. Avital, T. Kreisel, S. Zubedat, R. Eavri, M. Segal, R. Yirmiya, and E. Keshet Reversible modulations of neuronal plasticity by VEGF Proceedings of the National Academy of Sciences of the United States of America 108 2011 5081 5086
38. D.A. Long, W. Mu, K.L. Price, and R.J. Johnson Blood vessels and the aging kidney Nephron Experimental Nephrology 101 2005 e95 99
39. C. Luppi, M. Fioravanti, B. Bertolini, M. Inguscio, A. Grugnetti, F. Guerriero, C. Rovelli, F. Cantoni, P. Guagnano, E. Marazzi, E. Rolfo, D. Ghianda, D. Levante, C. Guerrini, R. Bonacasa, and S.B. Solerte Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS) Archives of Gerontology and Geriatrics 49 Suppl. 1 2009 173 184
40. M. Martino, G. Rocchi, A. Escelsior, and M. Fornaro Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance Current Neuropharmacology 10 2012 97 123
41. A. Minelli, R. Zanardini, M. Abate, M. Bortolomasi, M. Gennarelli, and L. Bocchio-Chiavetto Vascular endothelial growth factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 2011 1322 1325
42. R. Miyazaki, T. Ichiki, T. Hashimoto, J. Ikeda, A. Kamiharaguchi, E. Narabayashi, H. Matsuura, K. Takeda, and K. Sunagawa Acetylcholinesterase inhibitors attenuate angiogenesis Clinical Science 2012 (Lond)
43. F. Mor, F.J. Quintana, and I.R. Cohen Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization Journal of Immunology 172 2004 4618 4623
44. M. Nauck, G. Karakiulakis, A.P. Perruchoud, E. Papakonstantinou, and M. Roth Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells European Journal of Pharmacology 341 1998 309 315
45. M.M. Nowacka, and E. Obuchowicz Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action Neuropeptides 46 2012 1 10
46. K.E. Ohlin, V. Francardo, H.S. Lindgren, S.E. Sillivan, S.S. O'Sullivan, A.S. Luksik, F.M. Vassoler, A.J. Lees, C. Konradi, and M.A. Cenci Vascular endothelial growth factor is upregulated by l-dopa in the parkinsonian brain: implications for the development of dyskinesia Brain 134 2011 2339 2357
47. A. Pillai, and S.P. Mahadik Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus Schizophrenia Research 87 2006 48 59
48. R.S. Robinson, K.J. Woad, A.J. Hammond, M. Laird, M.G. Hunter, and G.E. Mann Angiogenesis and vascular function in the ovary Reproduction 138 2009 869 881
49. L.E. Rueter, C. De Montigny, and P. Blier Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems Journal of Pharmacology and Experimental Therapeutics 285 1998 404 412
50. L.E. Rueter, K. Kasamo, C. de Montigny, and P Blier Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain Naunyn-Schmiedebergs Archiv fur Experimentelle Pathologie und Pharmacologie 357 1998 600 610
51. C. Schmidt-Lucke, F. Belgore, D. Reinhold, S. Ansorge, H.U. Klein, J.A. Schmidt-Lucke, and G.Y. Lip Soluble vascular endothelial growth factor, soluble VEGF receptor Flt-1 and endothelial function in healthy smokers International Journal of Cardiology 100 2005 207 212
52. E. Segi-Nishida, J.L. Warner-Schmidt, and R.S. Duman Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus Proceedings of the National Academy of Sciences of the United States of America 105 2008 11352 11357
53. A. Soumier, M. Banasr, S. Lortet, F. Masmejean, N. Bernard, L. Kerkerian-Le-Goff, C. Gabriel, M.J. Millan, E. Mocaer, and A. Daszuta Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus Neuropsychopharmacology 34 2009 2390 2403
54. R. Sun, N. Li, and T. Li VEGF regulates antidepressant effects of lamotrigine European Neuropsychopharmacology 2011
55. M. Takebayashi, R. Hashimoto, K. Hisaoka, M. Tsuchioka, and H. Kunugi Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders Journal of Neural Transmission 117 2010 1119 1122
56. W.D. Taylor, H.J. Aizenstein, and G.S. Alexopoulos The vascular depression hypothesis: mechanisms linking vascular disease with depression Molecular Psychiatry 2013
57. M.H. Trivedi, D. Desaiah, M.J. Ossanna, Y.L. Pritchett, S.K. Brannan, and M.J. Detke Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine International Clinical Psychopharmacology 23 2008 161 169
58. S.J. Tsai, C.J. Hong, Y.J. Liou, T.J. Chen, M.L. Chen, S.J. Hou, F.C. Yen, and Y.W. Yu Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder Psychiatry Research 169 2009 113 117
59. M. Ventriglia, R. Zanardini, L. Pedrini, A. Placentino, M.G. Nielsen, M. Gennarelli, and L. Bocchio-Chiavetto VEGF serum levels in depressed patients during SSRI antidepressant treatment Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 2009 146 149
60. J. Ventura, R.P. Liberman, M.F. Green, A. Shaner, and J. Mintz Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P) Psychiatry Research 79 1998 163 173
61. M. Viikki, S. Anttila, O. Kampman, A. Illi, M. Huuhka, E. Setala-Soikkeli, N. Mononen, T. Lehtimaki, and E. Leinonen Vascular endothelial growth factor (VEGF) polymorphism is associated with treatment resistant depression Neuroscience Letters 477 2010 105 108
62. J.L. Warner-Schmidt, and R.S. Duman VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants Proceedings of the National Academy of Sciences of the United States of America 104 2007 4647 4652
63. J.L. Warner-Schmidt, and R.S. Duman VEGF as a potential target for therapeutic intervention in depression Current Opinion in Pharmacology 8 2008 14 19
64. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer A rating scale for mania: reliability, validity and sensitivity The British Journal of Psychiatry 133 1978 429 435
65. C.L. Zhou, X.J. Yu, L.M. Chen, H. Jiang, and C.Y. Li Corticotropin- releasing hormone attenuates vascular endothelial growth factor release from human HaCaT keratinocytes Regulatory Peptides 160 2010 115 120